关注
Pouya Dehghankelishadi
Pouya Dehghankelishadi
在 monash.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Hyaluronic acid-coated liposomes for targeted delivery of paclitaxel, in-vitro characterization and in-vivo evaluation
F Ravar, E Saadat, M Gholami, P Dehghankelishadi, M Mahdavi, S Azami, ...
Journal of Controlled Release 229, 10-22, 2016
1962016
Pluronic F127 polymeric micelles for co-delivery of paclitaxel and lapatinib against metastatic breast cancer: preparation, optimization and in vitro evaluation
P Dehghan Kelishady, E Saadat, F Ravar, H Akbari, F Dorkoosh
Pharmaceutical development and technology 20 (8), 1009-1017, 2015
692015
Evaluation of a novel biocompatible magnetic nanomedicine based on beta-cyclodextrin, loaded doxorubicin-curcumin for overcoming chemoresistance in breast cancer
R Rastegar, H Akbari Javar, M Khoobi, P Dehghan Kelishadi, ...
Artificial cells, nanomedicine, and biotechnology 46 (sup2), 207-216, 2018
442018
Liposomal formulation for co-delivery of paclitaxel and lapatinib, preparation, characterization and optimization
F Ravar, E Saadat, PD Kelishadi, FA Dorkoosh
Journal of liposome research 26 (3), 175-187, 2016
402016
In vitro and in vivo evaluation of paclitaxel–lapatinib-loaded F127 pluronic micelles
P Dehghankelishadi, E Saadat, F Ravar, M Safavi, M Pordeli, M Gholami, ...
Drug development and industrial pharmacy 43 (3), 390-398, 2017
212017
Development and validation of rapid stability-indicating RP-HPLC-DAD method for the quantification of lapatinib and mass spectrometry analysis of degraded products
E Saadat, P Dehghan Kelishady, F Ravar, F Kobarfard, FA Dorkoosh
Journal of chromatographic science 53 (6), 932-939, 2015
212015
Development and Validation of Rapid RP-HPLC-DAD Analysis Method for Simultaneous Quantitation of Paclitaxel and Lapatinib in Polymeric Micelle Formulation
E Saadat, F Ravar, P Dehghankelishadi, FA Dorkoosh
Scientia pharmaceutica 84 (2), 333-345, 2016
172016
Pluronic based nano-delivery systems; Prospective warrior in war against cancer
P Dehghankelishadi, F Dorkoosh
Nanomedicine Research Journal 1 (1), 1-7, 2016
142016
Formulation of simvastatin within high density lipoprotein enables potent tumour radiosensitisation
P Dehghankelishadi, MF Maritz, N Dmochowska, P Badiee, E Cheah, ...
Journal of Controlled Release 346, 98-109, 2022
122022
High density lipoprotein nanoparticle as delivery system for radio-sensitising miRNA: An investigation in 2D/3D head and neck cancer models
P Dehghankelishadi, MF Maritz, P Badiee, B Thierry
International Journal of Pharmaceutics 617, 121585, 2022
122022
Tailoring Gold Nanocluster Properties for Biomedical Applications: From Sensing to Bioimaging and Theranostics
SM Farkhani, P Dehghankelishadi, A Refaat, DV Gopal, A Cifuentes-Rius, ...
Progress in Materials Science, 101229, 2023
92023
Development of Octreotide-Loaded Chitosan and Heparin Nanoparticles: Evaluation of Surface Modification Effect on Physicochemical Properties and Macrophage Uptake
M Ghofrani, LR Shirmard, P Dehghankelishadi, M Amini, FA Dorkoosh
Journal of pharmaceutical sciences 108 (9), 3036-3045, 2019
72019
Preparation, Optimization and Physicochemical Characterization of Aripiprazole Loaded Nano-porous in situ Forming Implant
A Hedayati, S G Yazdi, P Dehghankelishadi, N B Javan, H Akbari, ...
Pharmaceutical nanotechnology 5 (2), 138-147, 2017
42017
Novel pH-responsive multilayer magnetic nanoparticles for controlled drug delivery
SF Motevalizadeh, M Khoobi, N Babanejad, E Mohit, P Dehghankelishadi, ...
Journal of the Iranian Chemical Society 13, 1653-1666, 2016
42016
Bosutinib high density lipoprotein nanoformulation has potent tumour radiosensitisation effects
P Dehghankelishadi, P Badiee, MF Maritz, N Dmochowska, B Thierry
Journal of Nanobiotechnology 21 (1), 102, 2023
22023
Insights into Targeted and Stimulus‐Responsive Nanocarriers for Brain Cancer Treatment
Z Abousalman‐Rezvani, A Refaat, P Dehghankelishadi, ...
Advanced Healthcare Materials 13 (12), 2302902, 2024
2024
Hydrophobic ion pairing and microfluidic nanoprecipitation enable efficient nanoformulation of a small molecule indolamine 2, 3‐dioxygenase inhibitor immunotherapeutic
P Badiee, MF Maritz, P Dehghankelishadi, N Dmochowska, B Thierry
Bioengineering & Translational Medicine 9 (1), e10599, 2024
2024
系统目前无法执行此操作,请稍后再试。
文章 1–17